BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 112 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $119,572 | +166.1% | 24,156 | 0.0% | 0.00% | – |
| Q1 2023 | $44,930 | +3.9% | 24,156 | 0.0% | 0.00% | – |
| Q4 2022 | $43,240 | +5.5% | 24,156 | +0.0% | 0.00% | – |
| Q3 2022 | $41,000 | -35.9% | 24,145 | -7.3% | 0.00% | – |
| Q2 2022 | $64,000 | -11.1% | 26,036 | 0.0% | 0.00% | – |
| Q1 2022 | $72,000 | -49.7% | 26,036 | 0.0% | 0.00% | – |
| Q4 2021 | $143,000 | -47.8% | 26,036 | +205.7% | 0.00% | – |
| Q4 2020 | $274,000 | – | 8,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $86,074,000 | 4.50% |
| Boxer Capital, LLC | 2,014,858 | $50,271,000 | 3.43% |
| RA Capital Management | 2,589,904 | $64,618,000 | 2.04% |
| Artal Group S.A. | 1,696,517 | $42,328,000 | 1.79% |
| Logos Global Management LP | 123,465 | $2,772,000 | 1.05% |
| BVF INC/IL | 378,788 | $9,451,000 | 0.88% |
| Casdin Capital, LLC | 289,395 | $7,220,000 | 0.77% |
| Perceptive Advisors | 1,104,656 | $27,561,000 | 0.72% |
| Bellevue Group AG | 1,330,000 | $33,184,000 | 0.64% |
| Vivo Capital, LLC | 252,119 | $6,290,000 | 0.57% |